SBFC Finance IPO and Concord Biotech IPO open for subscription, analysts bullish on both. Some experts have given preference to SBFC Finance IPO. Read on to know why:
The retail portion of the IPO was subscribed 3.67 times and the NII category was booked 7.7 times. The part reserved for qualified institutional buyers (QIB) was subscribed just 52% so far.
"Considering the subdued ROE profile of the company as well as high post-issue adequacy of 50%, return ratios are expected to remain under pressure in coming years. We have a cautious view on the issue," said Incred Equities.
SBFC Finance IPO opens today: It has seen consistent improvement in asset quality, with the gross non-performing assets in FY23 falling 31 basis points year-on-year to 2.43 percent